Scroll Back to Top
Accessibility
Accessibility
May 31, 2023

Labcorp Plasma Focus™ liquid biopsy test now available

Liquid biopsy tes t for cancer patients enables oncologists to identify targeted therapies and improve care BURLINGTON, N.C. , May 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted
Read more »
Publication
Rebecca A. Previs, Heidi C. Ko, Kyle C. Strickland, Eric A. Severson, Prasanth Reddy, Shakti Ramkissoon, Jonathan Klein
Publication
Idoko Salifu (a), Navneet Singh (b), Maria Berraondo (a), Jordi Remon (c), Stephanie Salifu (d),
Eric Severson (a), Angela Quintana (e), Sandra Peir´o (e), Shakti Ramkissoon (a,f), Laura Vidal (a),
Isagani Chico (a), Kamal S. Saini (a,g)

a Labcorp Drug Development Inc., Princeton, NJ, USA
b Postgraduate Institute of Medical Education and Research, Chandigarh, India
c Paris-Saclay University, department of Cancer Medicine, Gustave Roussy, Villejuif, France
d Dix Hills, NY, USA
e Vall d’Hebron Institute of Oncology, Barcelona, Spain
f Department of Pathology, Wake Forest School of Medicine and Comprehensive Cancer Center, Winston-Salem, NC, USA
g Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Subscribe to